Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.
/PRNewswire/ AKI is also associated with long-term risks of Chronic Kidney Disease (CKD), End Stage Kidney Disease (ESKD), and other organ dysfunction in.